Press Release: Abacus dx Announces Partnership with Roche in Australia’s Life Science sector
Abacus dx Announces Commercial Partnership with Roche in Australia’s Life Science sector
Brisbane, 1st June 2024
Abacus dx is thrilled to announce a new commercial partnership with Roche. This partnership marks a significant expansion of our product offerings in the Life Sciences sector only. This collaboration unites Abacus dx’s extensive distribution network with Roche’s innovative solutions for the Life Science sector, furthering our commitment to advancing research, academic and biotechnology capabilities across Australia.
With its 125-year legacy of pioneering healthcare innovation, Roche stands at the forefront of the biotechnology industry. As a global leader in in-vitro diagnostics and a major supplier of groundbreaking solutions for significant disease areas, Roche’s reputation for excellence aligns with Abacus dx’s mission to deliver top-tier medical technologies to our customers.
Effective June 1st, 2024, Abacus dx will distribute Roche’s Life Science products in Australia. Our portfolio will feature advanced Molecular Diagnostics hardware and reagents such as the LightCycler® 96 System, LightCycler® 480 II System, MagNA Pure 24 System, and MagNA Pure 96 System. Additionally, we will offer Tissue Diagnostics solutions, including the Ventana Discovery Ultra and a suite of Sequencing Solutions reagents.
This partnership is a testament to Abacus dx’s dedication to enhancing the scientific community’s access to state-of-the-art technologies. Together with Roche, we are set to empower research, academic and biotechnology customers with the tools necessary for groundbreaking discoveries and advancements in the Life Science sector.
About Abacus dx:
Abacus dx distributes diagnostic pathology, medical research, and innovative laboratory equipment solutions to a range of healthcare practitioners. Our customers include private and public pathology laboratories, blood donor centres as well as universities, research institutes, biotechnology companies and veterinary laboratories.
At Abacus dx we consistently add value to our suppliers’ products through our unrivalled service provision and support. We are very proud to have grown to be the successful and award-winning company that we are today, having supported our customers with superior solutions for almost 60 years. Abacus dx is part of the Diploma Healthcare group, owned by Diploma PLC.
For enquiries and details on your local territory representative, please get in touch with Chiara Campo, Commercial Director, Abacus dx: c.campo@abacusdx.com.
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
